Higher Prevalence of HLA-Alloimmunization in Aplastic Anemia and MDS/MPN patients

被引：0
|
作者：
Tsamadou, C. [1 ,2 ]
Fuerst, D. [1 ,2 ]
Zollikofer, C. [1 ,2 ]
Schrezenmeier, H. [1 ,2 ]
Mytilineos, J. [1 ,2 ]
机构：
[1] Baden Wuerttemberg Hessen, German Red Cross Blood Transfus Serv, Ulm, Germany
[2] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P182
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [1] HIGHER PREVALENCE OF HLA-ALLOIMMUNIZATION IN APLASTIC ANEMIA AND MDS/MPN PATIENTS
    Tsamadou, Chrysanthi
    Fuerst, Daniel
    Zollikofer, Christine
    Schrezenmeier, Hubert
    Mytilineos, Joannis
    TISSUE ANTIGENS, 2015, 85 (05): : 355 - 356
  • [2] HLA-Alloimmunization in acquired aplastic anemia
    Julen, Katja
    Volken, Thomas
    Holbro, Andreas
    Infanti, Laura
    Halter, Jorg
    Schaub, Stefan
    Diesch, Tamara
    Passweg, Jakob
    Buser, Andreas
    Drexler, Beatrice
    BONE MARROW TRANSPLANTATION, 2019, 54 : 31 - 31
  • [3] Prevalence of HLA-alloimmunization in patients referred for unrelated stem cell donor search
    Fuerst, Daniel
    Platzbecker, Uwe
    Wais, Verena
    Bunjes, Donald
    Wagner-Drouet, Eva
    Gramatzki, Martin
    Wulf, Gerald
    Tsamadou, Chrysanthi
    Schrezenmeier, Hubert
    Mytilineos, Joannis
    BONE MARROW TRANSPLANTATION, 2019, 54 : 567 - 568
  • [4] HLA-ALLOIMMUNIZATION IN UNRELATED DONOR SEARCH - PREVALENCE IN SELECTED DISEASE ENTITIES
    Fuerst, Daniel
    Platzbecker, Uwe
    Wais, Verena
    Bunjes, Donald
    Wagner, Eva
    Gramatzki, Martin
    Wulf, Gerald
    Tsamadou, Chrysanthi
    Schrezenmeier, Hubert
    Mytilineos, Joannis
    HLA, 2019, 93 (05) : 372 - 373
  • [5] HLA alloimmunization in Egyptian aplastic anemia patients receiving exclusively leukoreduced blood components
    Enein, Azza Ahmed Aboul
    El Desoukey, Nermeen Ahmed
    Hussein, Eiman Abdel Wahab
    Hamdi, Mona
    Jamjom, Nada Adnan
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 48 (02) : 213 - 218
  • [6] HLA Alloimmunization in Egyptian Patients with Aplastic Anemia Receiving Exclusively Leukoreduced Blood Components
    Hussein, E. A.
    Enein, A. A.
    Desooky, N.
    TRANSFUSION, 2010, 50 : 127A - 127A
  • [7] HLA-ALLOIMMUNIZATION IN PATIENTS WITH HUNTERS SYNDROME RECEIVING RANDOM OR HLA-MATCHED LEUKOCYTE TRANSFUSIONS
    KAKAIYA, R
    GREENSTEIN, R
    CABLE, R
    PISCIOTTO, P
    SLOCUM, S
    ROSEN, D
    MORSE, EE
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1983, 13 (04): : 342 - 342
  • [8] Transfusions in Aplastic Anemia Patients Cause HLA Alloimmunization: Comparisons of Current and Past Cohorts Demonstrate Progress
    Julen, Katja
    Volken, Thomas
    Holbro, Andreas
    Infanti, Laura
    Halter, Jorg P.
    Schaub, Stefan
    Wehmeier, Caroline
    Diesch, Tamara
    Rovo, Alicia
    Passweg, Jakob R.
    Buser, Andreas
    Drexler, Beatrice
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 939.e1 - 939.e8
  • [9] Increased RBC Alloimmunization Rates in Aplastic Anemia and Myelofibrosis Patients
    Sotolongo, Gina L.
    Poisson, Jessica
    TRANSFUSION, 2021, 61 : 235A - 236A
  • [10] Significance of HLA-DR15 haplotype in Japanese patients with aplastic anemia (AA) or myelodysplastic syndrome (MDS).
    Andoh, S
    Tsunoda, Y
    Okamoto, M
    Maruyama, Y
    Shichishima, T
    BLOOD, 2002, 100 (11) : 232A - 232A
12345